ALFA Filings
Every announcement, straight from the exchange
Every Mahamaya Lifesciences other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Mahamaya Lifesciences Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Mahamaya Lifesciences Limited has been awarded the "Quality Excellence Award-Adherence to Global Quality Standards (GMP)" by Business Connect. The recognition highlights the company's commitment to global manufacturing standards and quality excellence. This award serves as a positive validation of the company's operational processes and quality management systems.
Mahamaya Lifesciences Limited has been awarded the 'Great Place to Work' certification in India for the 'Under 100 Employees' category. The certification is valid from April 2026 to April 2027, recognizing the company's commitment to building a high-trust, high-performance workplace culture.
Mahamaya Lifesciences Ltd informed BSE that it is exempt from filing quarterly Corporate Governance Reports under Regulation 27(2) of SEBI LODR. This exemption applies as the company is listed on the BSE SME Platform and fulfills criteria under Regulation 15(2). This is a routine regulatory compliance notification.
Mahamaya Lifesciences Ltd submitted its annual declaration under SEBI (SAST) Regulations for the financial year ended March 31, 2026. The promoter and promoter group confirmed that no encumbrances were created on their shareholding during the period. This routine compliance filing affirms stable promoter holding and absence of fresh pledges.